Letter
Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer
de Paula B, Cexus O, Townsend P & Crocamo S (2025) Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer. Asian Journal of Surgery, 48 (1), pp. 566-567. https://doi.org/10.1016/j.asjsur.2024.07.024
Article
Automated Liquid Handling Extraction and Rapid Quantification of Underivatized Amino Acids and Tryptophan Metabolites from Human Serum and Plasma Using Dual-Column U(H)PLC-MRM-MS and Its Application to Prostate Cancer Study
Kipura T, Hotze M, Hofer A, Egger A, Timpen LE, Opitz CA, Townsend PA, Gethings LA, Thedieck K & Kwiatkowski M (2024) Automated Liquid Handling Extraction and Rapid Quantification of Underivatized Amino Acids and Tryptophan Metabolites from Human Serum and Plasma Using Dual-Column U(H)PLC-MRM-MS and Its Application to Prostate Cancer Study. Metabolites, 14 (7), Art. No.: 370. https://doi.org/10.3390/metabo14070370
Article
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, Murphy N, Burrows K, Bouras E, Smith-Byrne K, Lewis SJ, Galesloot TE, Kiemeney LA, Vermeulen S & Townsend PA (2024) Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. eBioMedicine, 100, Art. No.: 104991. https://doi.org/10.1016/j.ebiom.2024.104991
Article
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
Watts EL, Gonzales TI, Strain T, Saint-Maurice PF, Bishop DT, Chanock SJ, Johansson M, Keku TO, Le Marchand L, Moreno V, Newcomb PA, Newton CC, Pai RK, Purdue MP & Townsend PA (2024) Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study. British Journal of Cancer, 130, pp. 114-124. https://doi.org/10.1038/s41416-023-02489-3